Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Acute Spinal Cord Injury Industry In 2025?
The market size for acute spinal cord injury has shown strong growth in recent years. It is anticipated to expand from $6.7 billion in 2024 to $7.06 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.4%. The expansion observed in the past can be ascribed to a rise in the incidence of acute spinal cord injuries, enhanced public awareness regarding acute spinal cord injury and its treatment alternatives, an escalating demand for personalized medical attention, increasing levels of disposable income, and greater government expenditure on ASCI research and development.
The acute spinal cord injury market size is projected to experience robust expansion over the forthcoming years. It is forecast to reach $8.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period can be attributed to the development of emerging therapies, the increased adoption of telemedicine, the implementation of patient-centric care models, and a heightened focus on preventive healthcare and injury prevention. Prominent trends observed within this period include continuous medical advancements, innovative rehabilitation techniques, the introduction of neuroprotection therapies, comprehensive psychosocial support, and strong advocacy and accessibility initiatives.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12960&type=smp
Which Drivers Are Supporting Growth Of The Acute Spinal Cord Injury Market?
The acute spinal cord injury market is anticipated to be boosted by the rising number of road accidents in the future. A road accident is defined as an incident involving a motor vehicle collision that results in injuries or severe fatalities. Accidental spinal injuries can harm the central nervous system (CNS), interrupting the transmission of nerves vital for function and sensory skills. The impact’s strength in an accident can cause trauma to the cervical, lumbar, or thoracic spine, potentially damaging or severing the spinal cord and leading to paralysis. For instance, in June 2024, the Llywodraeth Cymru / Welsh Government, a Wales-based government administration, reported that police forces in Wales recorded 4,348 road casualties in 2023, marking a 2% increase compared to 2022. Therefore, the increase in road accidents acts as a driver for the growth of the acute spinal cord injury market.
What Are The Major Segment Types Covered In The Acute Spinal Cord Injury Market?
The acute spinal cord injurymarket covered in this report is segmented –
1) By Type: Complete Spinal Cord Injury; Incomplete Spinal Cord Injury
2) By Diagnosis Type: Laboratory Tests; Imaging Tests
3) By Application: Hospitals; Clinics
Subsegments:
1) By Complete Spinal Cord Injury: Tetraplegia; Paraplegia
2) By Incomplete Spinal Cord Injury: Central Cord Syndrome; Anterior Cord Syndrome; Brown-Séquard Syndrome; Conus Medullaris Syndrome; Cauda Equina Syndrome
How Are Emerging Market Trends Shaping The Acute Spinal Cord Injury Industry Landscape?
Leading companies operating within the acute spinal cord injury market are concentrating on developing innovative medications to serve their clientele and secure their market standing. The creation of new drugs, such as LYVISPAH, holds the potential to enhance treatment outcomes for patients through the application of combination therapy. For example, in July 2022, Amneal Pharmaceuticals, a pharmaceutical company based in the US, introduced LYVISPAH, an oral baclofen granule (5, 10 and 20 mg) that received approval from the U.S. Food and Drug Administration (FDA) for managing spasticity linked to multiple sclerosis and other spinal cord disorders. LYVISPAH actively treats and alleviates flexor spasms, along with related pain, clones, and muscular rigidity. It offers flexible, customized dosage through single-dose granule packages in strengths of 5 mg, 10 mg, and 20 mg, and is bioequivalent to oral baclofen tablets. Furthermore, patients with spinal cord injuries and other spinal cord diseases may also find benefit from utilizing LYVISPAH.
Which Key Market Players Are Investing In Expansion And Innovation Of Acute Spinal Cord Injury Market?
Major companies operating in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report
Which Regional Markets Are Contributing Most To The Acute Spinal Cord Injury Industry Expansion?
North America was the largest region in the acute spinal cord injury market in 2024. The regions covered in acute spinal cord injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Acute Spinal Cord Injury Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12960&type=smp
Browse Through More Reports Similar to the Global Acute Spinal Cord Injury Market 2025, By The Business Research Company
Spine Implants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/spine-implants-global-market-report
Spinal Cord Stimulation Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report
Spinal Imaging Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/spinal-imaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
